monomethyl fumarate (Bafiertam)
Jump to navigation
Jump to search
Indications
- relapsing forms of multiple sclerosis
- clinically isolated syndrome
- relapsing-remitting disease
- active secondary progressive disease.
More general terms
References
- ↑ Medscape. Aug 14, 2020 FDA Drug Approvals, Internal Medicine - 2020 Midyear Review. https://reference.medscape.com/viewarticle/935373